Explorer
Advertisement
Drugs Controller General Of India
Health
'Blood Is Not For Sale': DCGI's Big Move To Curb Overcharging By Hospitals, Blood Banks
India
'Himachal's Baddi Becoming 'Hub' Of Spurious Drugs': NHRC Notice To Health Ministry, DCGI And FSSAI
India
Licences Of 18 Pharma Firms Cancelled For Manufacturing Spurious Drugs: Report
Science
Explained: As India Unveils SII's CERVAVAC, Know How Cervical Cancer Vaccines Work
Health
Cervical Cancer Vaccine To Be Available In Few Months, To Be Priced Between Rs 200-400: Adar Poonawalla
Health
SII To Launch India's First Indigenously Developed Vaccine Against Cervical Cancer Tomorrow
India
BREAKING | DCGI Gives Nod To Covaxin For Restricted EUA For Inoculation In Children Aged 6-12
India
SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years
India
Biological E Applies For EUA For Covid-19 Vaccine Corbevax For 5-12 Age Group: Report
Health
Covid Vaccine: Bharat Biotech Gets DCGI Permission For Intranasal Booster Dose Trials
India
Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population
News
SII Gets DCGI Nod To Manufacture Drug Substance, Test It For Developing Jab Against Omicron
Short Videos
Advertisement
Advertisement
Advertisement
Top Headlines
India
World
Technology
World
Advertisement